Corvus Pharmaceuticals CRVS
NASDAQ CRVS
$11.52 -0.24 (-2.04%)
At close: Sep 30, 2026 · 4:00 PM EDT

Corvus Pharmaceuticals (CRVS) Other Non-Current Assets (2015 - 2026)

Updated

Corvus Pharmaceuticals (CRVS) posted Other Non-Current Assets of $1.71 million for Q2 2026, up 173.6% from $626,000 a year earlier but down 0.4% from the prior quarter.

Analysis

Corvus Pharmaceuticals (CRVS) Other Non-Current Assets (2015 - 2026) Analysis & Trends

At the end of FY2025, Corvus Pharmaceuticals' Other Non-Current Assets came in at $855,000, up 35.3% from FY2024.

  • Annual Other Non-Current Assets shows a five-year compound annual growth rate of 15.6% (FY2020 to FY2025).
  • In prior years, Corvus Pharmaceuticals' Other Non-Current Assets was $632,000 in FY2024 (+610.1%), $89,000 in FY2023 (-31.0%), $129,000 in FY2022 (-45.3%) and $236,000 in FY2021 (-43.0%).
  • Quarterly Other Non-Current Assets has run from a low of $89,000 in Q3 2023 to a high of $1.72 million in Q1 2026 over five years.
  • On a year-over-year basis, Other Non-Current Assets has increased in each of the last eight quarters, with growth averaging 300.7% over the last eight quarters.
  • The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q4 2024, with growth of 610.1%; the weakest was Q1 2022, with a decline of 78.1%.
  • According to Business Quant data, Other Non-Current Assets for the three prior quarters was $1.72 million (Q1 2026), $855,000 (Q4 2025) and $852,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Corvus Pharmaceuticals 969.07 Mn 457.51 Mn - 1.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.71 Mn
Mar 31, 2026 1.72 Mn
Dec 31, 2025 855,000.00
Sep 30, 2025 852,000.00
Jun 30, 2025 626,000.00
Mar 31, 2025 629,000.00
Dec 31, 2024 632,000.00
Sep 30, 2024 252,000.00
Jun 30, 2024 129,000.00
Mar 31, 2024 89,000.00
Dec 31, 2023 89,000.00
Sep 30, 2023 89,000.00
Jun 30, 2023 129,000.00
Mar 31, 2023 129,000.00
Dec 31, 2022 129,000.00
Sep 30, 2022 248,000.00
Jun 30, 2022 236,000.00
Mar 31, 2022 236,000.00
Dec 31, 2021 236,000.00
Sep 30, 2021 279,000.00
API Access

Corvus Pharmaceuticals Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CRVS&period=max&api_key=YOUR_API_KEY